What is a straightforward protocol for starting warfarin and establishing the appropriate maintenance dose in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Warfarin Initiation Protocol for Adults

Start warfarin at 2-5 mg daily (typically 5 mg for most adults, 2-4 mg for elderly ≥60 years), overlap with parenteral anticoagulation (LMWH or UFH) for at least 5 days and until INR is 2.0-3.0 for 2 consecutive days, then adjust dose based on INR response using a standardized algorithm. 1

Initial Dosing Strategy

Starting Dose Selection

  • Standard adults (<60 years): 5 mg daily 1
  • Elderly (≥60 years): 2-4 mg daily 1
  • Patients with liver dysfunction or high bleeding risk: 2-4 mg daily 1

Critical: Do NOT use loading doses >10 mg - they increase bleeding risk without providing faster therapeutic anticoagulation 1

Mandatory Bridging Therapy

You must overlap warfarin with parenteral anticoagulation for acute VTE treatment 2, 3, 2:

  • UFH: 80 U/kg IV bolus, then 18 U/kg/hour, adjust by aPTT 2, 3, 2
  • Enoxaparin: 1 mg/kg SC every 12 hours OR 1.5 mg/kg once daily 2, 3, 2
  • Dalteparin: 200 U/kg SC once daily 2, 3, 2

Continue parenteral anticoagulation for minimum 5 days AND until INR ≥2.0 for 2 consecutive days 2, 1

INR Monitoring Schedule

Week 1

  • Day 1: Start warfarin + parenteral anticoagulant
  • Day 3-4: Check first INR 4, 5
  • Daily INR checks until stable in therapeutic range 1

After Therapeutic INR Achieved

  • Check INR every 1-4 weeks once maintenance dose established 1
  • More frequent monitoring needed when:
    • Starting/stopping other medications
    • Dietary changes
    • Illness or surgery

Dose Adjustment Algorithm

Target INR: 2.0-3.0 (for most indications including VTE, atrial fibrillation) 2, 3, 2, 1

Adjustment Table

INR Result Action
<1.5 Increase weekly dose by 10-20%
1.5-1.9 Increase weekly dose by 5-10%
2.0-3.0 No change - therapeutic range
3.1-4.0 Decrease weekly dose by 5-10%
4.1-5.0 Hold 0-1 dose, decrease weekly dose by 10-15%
5.1-9.0 Hold 1-2 doses, give vitamin K 1-2.5 mg PO if bleeding risk, restart at 10-20% lower dose [6]
>9.0 Hold warfarin, give vitamin K 3-5 mg PO, monitor closely [6]
>10 with bleeding Hold warfarin, give vitamin K 10 mg IV slow infusion + fresh frozen plasma or prothrombin complex concentrate [6,7]

Practical Protocol Example (5 mg Start)

Day 1-3: Warfarin 5 mg daily + parenteral anticoagulant

Day 4: Check INR

  • INR <1.5: Continue 5 mg daily
  • INR 1.5-1.9: Continue 5 mg daily
  • INR 2.0-3.0: Continue 5 mg, recheck INR next day
  • INR >3.0: Hold 1 dose, restart at 2.5-3.75 mg

Day 5-7: Continue daily INR checks, adjust as above

Once INR therapeutic × 2 consecutive days: Stop parenteral anticoagulant, continue warfarin at current dose

Expected time to therapeutic INR: 5-7 days on average 1, 4, 5

Alternative Low-Dose Protocol for Elderly

For patients ≥70 years, a 4 mg daily × 3 days protocol is safer 4:

  • Give 4 mg daily for 3 days
  • Check INR on day 4
  • Use day 4 INR to predict maintenance dose (typically 3-4 mg daily)
  • This approach has 0% risk of INR >4.0 in elderly patients 4

Common Pitfalls to Avoid

  1. Starting warfarin alone without bridging in acute VTE - warfarin causes transient hypercoagulability in first 3-5 days due to protein C/S depletion before factor II/X depletion 8

  2. Stopping parenteral anticoagulation too early - must wait for INR ≥2.0 × 2 consecutive days, not just one therapeutic INR 2, 1

  3. Using excessive loading doses - doses >10 mg increase bleeding without faster therapeutic effect 1

  4. Inadequate monitoring frequency - daily INR checks needed until stable, then weekly until maintenance dose established 1

  5. Not adjusting for elderly patients - patients ≥60 years need lower starting doses (2-4 mg) due to increased sensitivity 1

Duration of Therapy

  • Provoked VTE (surgery, trauma): 3 months 1
  • Unprovoked VTE, first episode: 6-12 months minimum 1
  • Recurrent VTE: Indefinite therapy 1
  • Atrial fibrillation: Indefinite (as long as risk factors persist) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.